Untangling the mechanisms of white matter damage in cerebral hypoperfusion

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

August 30, 2027
Response Due
Active
Status

Opportunity Overview

White matter makes up over half of the human brain and its proper function is critical for fast communication between neurons. White matter damage that occurs during ageing and dementia is linked to chronically lowered brain blood flow (hypoperfusion) and appears to involve complex changes in multiple cell types in blood vessels and surrounding brain tissue at different times after disease onset. Progress in understanding these processes has been restricted by an inability to track cellular changes over time, and a lack of understanding of how one of the major targets, oligodendrocytes (cells which ensheath neurons allowing them to send fast signals), actually are damaged. However, our novel approach will allow major breakthroughs in understanding how white matter becomes damaged. We developed a new method that allows us to image different brain cells and blood vessels in a major white matter tract - the corpus callosum - of awake mice. Our approach feeds data from these new measurements into experiments in brain slices that allow underlying mechanisms to be identified, before in turn testing whether interfering with these mechanisms protects live mice from experiencing white matter damage during chronic cerebral hypoperfusion. By engaging a vital dialogue between these two approaches, we aim to untangle the processes by which white matter becomes damaged during chronically lowered brain blood flow and identify possible therapeutic targets.

We will first measure the reduction in white matter oxygenation (hypoxia) during a model of chronic cerebral hypoperfusion in awake mice, and characterise tissue and cell damage in post mortem tissue. We will then recreate these levels of oxygenation in brain slices to understand what mechanisms in white matter cells are impacted by this level of hypoxia. To understand how cell function changes during hypoperfusion, we will track, in vivo functional changes due to hypoperfusion in lots of white matter cells (oligodendrocytes,...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedAugust 31, 2023
Procurement stageActive solicitation
Response dueAugust 30, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.